Wells Fargo said in a July 19 note that the acquisition is likely under FTC scrutiny, the report said. Reports from Capitol Forum also said the deal could give physicians fewer options for medical devices.
The deal spread widened from $2.87 to $3.31, according to Seeking Alpha. Shareholders from Globus Medical and NuVasive approved the deal in April.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
